About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 325 record(s)
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Nothing to report this month
Organization: Canada Energy Regulator
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2022-00001
For both the CFO and DCFO positions: - the actual classification level of the positions, - a copy of the current work descriptions - a copy of the associated classification evaluation reports; Also an organization chart for positions reporting to the CFO or any document indicating whether the CFO is responsible for functional areas other than finance such as: - Contracting & Procurement, - IM /IT, - Human Resources, - Real Property (Facilities), - Inventory Management, - Materiel Management, - Corporate Security, - Business Planning (Strat Plan, DP, DR), - Corporate Communications, - OtherOrganization: Canada Energy Regulator
September 2022
Req # A-2022-01918
Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.Organization: Patented Medicine Prices Review Board Canada
September 2022
Req # A-2021-00023
Provide 2020, 2021 records, including memos, briefings, report on CER energy climate change planning, reports. Include 2020,2021 analyses of oil and gas wells, pipelines emissions and effect on climate change. Include 2020, 2021 estimates CER has done on greenhouse gas emissions, and 2020, 2021 estimates on phasing out fossil fuels. Provide 2020, 2021 reports, memos on effect climate change is or will have on CER regulation, regulation process. Provide 2020, 2021 discussions with federal senior authorities on tackling climate change within its regulatory mandate. Provide communications exchanged and meetings 2020, 2021 with CAPP representatives concerning their positions (and yours) on future oil and gas production, projections, phase-out and climate change factors influencing energy regulation.Organization: Canada Energy Regulator
August 2022
Req # A-2021-10763
Copies of all emails to/from/cc'ing all Directors from May 21, 2021 to May 30, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2022
Req # A-2021-10773
Copies of all emails sent by external sources to the PMPRB and Douglas Clark from May 22, 2021 to June 14, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2022
Req # A-2022-00003
Provide copies of all Statement of Work, and correspondence (director level or higher) related to the contract with 12348799 Canada Inc. (Procurement Identification Number 20-0135) referred to in this proactive disclosure report: search.open.Canada.ca/en/ct/id/cer-rec,C-2020-2021-Q4-00068Missing%20Q3Organization: Canada Energy Regulator
July 2022
Req # A-2022-13654
Electronic copies of the following documents: 1. A copy of every advance ruling certificate (ARC) issued by the Board, including any reasons in support of the ARC issued by the Board. 2. A copy of the Notice and Comment issued by the Board in response to each of the ARCs. 3. A copy of the patentee's submissions (including any affidavits or other evidence) on each of the ARCs. The Board's ARC for Viread indicates that these submissions are available upon request. 4. A copy of the Board Staff's submissions (including any affidavits or other evidence) on each of the ARCs. Again, the Board's Viread ARC indicates that these are available upon request. 5. A copy of any other submissions received in response to the notice of and comment.Organization: Patented Medicine Prices Review Board Canada
July 2022